A birth and baby nurse gives her personal take on using a GLP-1 after having a baby and talks through her own results.
Recap by typeshit. Video by Nurse Carly | birth & babies on TikTok.
Chokshi notes the sales were 0.4% of Lilly's $23 billion quarter, and that Divi's Labs hasn't announced any role in making the drug.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
She says the cause is a calorie surplus: some patients still manage high calorie foods and aren't exercising enough while on the drugs.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
In 2,749 adults with type 2 diabetes and high heart risk, Lilly's pill had fewer heart events and less low blood sugar, but GI side effects hit 62% of users.
In 2,749 people with type 2 diabetes, the daily pill also beat insulin on blood sugar and weight, though 62% reported stomach side effects. Results were presented at EASD.
Loading…